Cost-effectiveness of opt-out HCV and HBV testing in A&E in the UK


Research published in Value in Health in December 2020 found that testing for hepatitis C and hepatitis B in A&E departments in the UK is highly likely to be cost effective due to high rates of hepatitis among people who attend A&E. Based on a study of two London hospitals, the paper argues that, just as NICE guidelines recommend testing people attending A&E for HIV, hepatitis C and hepatitis B testing should also occur.